Search Orphan Drug Designations and Approvals
-
| Generic Name: | Heparin-binding epidermal growth factor-like growth factor |
|---|---|
| Date Designated: | 09/18/2006 |
| Orphan Designation: | Prevention and treatment of necrotizing enterocolitis (NEC) in preterm infants with birth weight less than 1,500 grams |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Trillium Therapeutics, Inc. 96 Skyway Avenue Toronto Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







